Private Wealth Management Group, LLC Celldex Therapeutics, Inc. Transaction History
Private Wealth Management Group, LLC
- $363 Billion
- Q3 2025
A detailed history of Private Wealth Management Group, LLC transactions in Celldex Therapeutics, Inc. stock. As of the latest transaction made, Private Wealth Management Group, LLC holds 28 shares of CLDX stock, worth $715. This represents 0.0% of its overall portfolio holdings.
Number of Shares
28
Previous 28
-0.0%
Holding current value
$715
Previous $570,000
27.19%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding CLDX
# of Institutions
206Shares Held
66.8MCall Options Held
222KPut Options Held
234K-
Kynam Capital Management, LP Princeton, NJ6.1MShares$156 Million13.34% of portfolio
-
Wellington Management Group LLP Boston, MA5.8MShares$148 Million0.03% of portfolio
-
Black Rock Inc. New York, NY4.69MShares$120 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.95MShares$101 Million0.0% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct3.89MShares$99.5 Million0.2% of portfolio
About Celldex Therapeutics, Inc.
- Ticker CLDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,772,400
- Market Cap $1.2B
- Description
- Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-01...